Showing results (201-210 of 384) with videos related to

Sort By:
Pageof 39
Immunity|November 25, 2010
Regulated expression of nuclear receptor RORγt confers distinct functional fates to NK cell receptor-expressing RORγt(+) innate lymphocytesCedric Vonarbourg, Arthur Mortha, Viet L Bui, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 9, 2021
Vasoactive intestinal peptide promotes host defense against enteric pathogens by modulating the recruitment of group 3 innate lymphoid cellsHong Bing Yu, Hyungjun Yang, Joannie M Allaire, et al.
Science Immunology|April 3, 2021
Human plasmacytoid dendritic cells mount a distinct antiviral response to virus-infected cellsTae Jin Yun, Suzu Igarashi, Haoquan Zhao, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 12, 2010
Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cellsCarl E Allen, Liunan Li, Tricia L Peters, et al.
Allergy|April 5, 2021
High-dimensional analysis defines multicytokine T-cell subsets and supports a role for IL-21 in atopic dermatitisTali Czarnowicki, Hyun Je Kim, Axel P Villani, et al.
The Journal of Experimental Medicine|November 13, 2024
The protozoan commensal Tritrichomonas musculis is a natural adjuvant for mucosal IgAEric Yixiao Cao, Kyle Burrows, Pailin Chiaranunt, et al.
The Journal of Experimental Medicine|March 5, 2014
Interplay of host microbiota, genetic perturbations, and inflammation promotes local development of intestinal neoplasms in miceGerold Bongers, Michelle E Pacer, Thais H Geraldino, et al.
Nature Medicine|March 19, 2013
CD169⁺ macrophages provide a niche promoting erythropoiesis under homeostasis and stressAndrew Chow, Matthew Huggins, Jalal Ahmed, et al.
Journal for Immunotherapy of Cancer|July 24, 2023
Pattern recognition receptor agonists in pathogen vaccines mediate antitumor T-cell cross-primingMark Aleynick, Judit Svensson-Arvelund, Gvantsa Pantsulaia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2020
Immunomodulation in Pomalidomide, Dexamethasone, and Daratumumab-Treated Patients with Relapsed/Refractory Multiple MyelomaWilliam E Pierceall, Michael D Amatangelo, Nizar J Bahlis, et al.
Pageof 39